chr6-6211186-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000129.4(F13A1):​c.1112+10847T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.144 in 152,262 control chromosomes in the GnomAD database, including 1,758 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 1758 hom., cov: 33)

Consequence

F13A1
NM_000129.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0550

Publications

3 publications found
Variant links:
Genes affected
F13A1 (HGNC:3531): (coagulation factor XIII A chain) This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13A1 Gene-Disease associations (from GenCC):
  • factor XIII, A subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000129.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13A1
NM_000129.4
MANE Select
c.1112+10847T>C
intron
N/ANP_000120.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
F13A1
ENST00000264870.8
TSL:1 MANE Select
c.1112+10847T>C
intron
N/AENSP00000264870.3
F13A1
ENST00000950947.1
c.1112+10847T>C
intron
N/AENSP00000621006.1
F13A1
ENST00000878383.1
c.923+10847T>C
intron
N/AENSP00000548442.1

Frequencies

GnomAD3 genomes
AF:
0.144
AC:
21910
AN:
152144
Hom.:
1760
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.173
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.134
Gnomad ASJ
AF:
0.217
Gnomad EAS
AF:
0.00250
Gnomad SAS
AF:
0.0810
Gnomad FIN
AF:
0.0757
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.152
Gnomad OTH
AF:
0.150
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.144
AC:
21922
AN:
152262
Hom.:
1758
Cov.:
33
AF XY:
0.139
AC XY:
10358
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.173
AC:
7192
AN:
41542
American (AMR)
AF:
0.133
AC:
2040
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.217
AC:
753
AN:
3468
East Asian (EAS)
AF:
0.00251
AC:
13
AN:
5188
South Asian (SAS)
AF:
0.0808
AC:
390
AN:
4826
European-Finnish (FIN)
AF:
0.0757
AC:
803
AN:
10610
Middle Eastern (MID)
AF:
0.190
AC:
56
AN:
294
European-Non Finnish (NFE)
AF:
0.152
AC:
10343
AN:
68008
Other (OTH)
AF:
0.148
AC:
313
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
984
1968
2951
3935
4919
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
3191
Bravo
AF:
0.149
Asia WGS
AF:
0.0530
AC:
186
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
6.4
DANN
Benign
0.73
PhyloP100
-0.055
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3024422; hg19: chr6-6211419; API